Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 7 studies | 34% ± 16% | |
| mast cell | 7 studies | 29% ± 15% | |
| pericyte | 6 studies | 40% ± 23% | |
| endothelial cell | 5 studies | 32% ± 8% | |
| glutamatergic neuron | 4 studies | 39% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 1013.69 | 242 / 245 | 96% | 25.18 | 484 / 502 |
| kidney | 99% | 689.43 | 88 / 89 | 75% | 4.51 | 679 / 901 |
| brain | 96% | 488.59 | 2529 / 2642 | 72% | 1.89 | 505 / 705 |
| pancreas | 93% | 221.85 | 306 / 328 | 69% | 4.36 | 122 / 178 |
| esophagus | 90% | 229.86 | 1295 / 1445 | 47% | 4.36 | 86 / 183 |
| stomach | 93% | 796.67 | 334 / 359 | 43% | 2.55 | 122 / 286 |
| thymus | 83% | 202.29 | 539 / 653 | 46% | 1.08 | 278 / 605 |
| liver | 82% | 157.83 | 185 / 226 | 46% | 2.28 | 186 / 406 |
| intestine | 84% | 187.70 | 807 / 966 | 39% | 2.23 | 207 / 527 |
| bladder | 90% | 217.95 | 19 / 21 | 21% | 1.33 | 104 / 504 |
| uterus | 95% | 265.61 | 161 / 170 | 9% | 0.35 | 40 / 459 |
| breast | 82% | 148.71 | 377 / 459 | 20% | 0.73 | 219 / 1118 |
| spleen | 100% | 1410.45 | 241 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 36% | 164.92 | 92 / 258 | 58% | 15.99 | 134 / 230 |
| adipose | 89% | 205.79 | 1074 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 64% | 80.59 | 516 / 803 | 0% | 0 | 0 / 0 |
| lung | 42% | 55.05 | 245 / 578 | 20% | 3.92 | 230 / 1155 |
| skin | 41% | 64.99 | 742 / 1809 | 19% | 1.37 | 90 / 472 |
| heart | 41% | 69.15 | 357 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 36% | 53.55 | 474 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 32% | 36.77 | 58 / 180 | 1% | 0.03 | 6 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.12 | 4 / 45 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.29 | 5 / 80 |
| peripheral blood | 4% | 3.99 | 37 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006814 | Biological process | sodium ion transport |
| GO_0003333 | Biological process | amino acid transmembrane transport |
| GO_1902475 | Biological process | L-alpha-amino acid transmembrane transport |
| GO_0016020 | Cellular component | membrane |
| GO_0015179 | Molecular function | L-amino acid transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC38A11 |
| Protein name | Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11) |
| Synonyms | AVT2 |
| Description | FUNCTION: Putative sodium-dependent amino acid/proton antiporter. . FUNCTION: Putative sodium-dependent amino acid/proton antiporter. . FUNCTION: Putative sodium-dependent amino acid/proton antiporter. . FUNCTION: Putative sodium-dependent amino acid/proton antiporter. . |
| Accessions | ENST00000409058.5 ENST00000685975.1 ENST00000409149.7 [Q08AI6-1] ENST00000409662.5 [Q08AI6-1] A0A8I5QKK7 B8ZZ86 Q08AI6 H7C1P1 ENST00000424914.1 ENST00000303735.8 [Q08AI6-2] |
